Augusta, GA, United States of America

David Munn

USPTO Granted Patents = 12 

Average Co-Inventor Count = 2.1

ph-index = 6

Forward Citations = 111(Granted Patents)


Company Filing History:


Years Active: 2002-2016

Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of David Munn

Introduction

David Munn is a prominent inventor based in Augusta, GA, known for his significant contributions to the field of medical research. With a total of 12 patents to his name, Munn has made strides in developing innovative treatment methods that enhance patient care.

Latest Patents

Among his latest patents is the invention titled "Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities." This invention provides improved treatment methods by administering both an inhibitor of indoleamine-2,3-dioxygenase alongside an additional therapeutic agent. This approach aims to enhance the efficacy of treatments for various medical conditions.

Career Highlights

David Munn has had a distinguished career, working with esteemed institutions such as the Medical College of Georgia Research Institute, Inc. and the Medical College of Georgia. His work has focused on advancing medical research and developing innovative therapies that address critical health issues.

Collaborations

Munn has collaborated with notable colleagues, including Andrew L Mellor and Jeffrey Roberts Lee. These partnerships have contributed to the success of his research and the development of his patents.

Conclusion

David Munn's innovative work and dedication to medical research have led to significant advancements in treatment methodologies. His contributions continue to impact the field positively, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…